Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • LOH
    Registered Vendor
    • Jul 2010
    • 23

    #1

    Research Associate I for Next Generation Sequencing

    Description

    Quick Biology, Inc. is a startup specialized in providing NGS service, NGS clinical diagnostics and assay development. We are seeking a Research Associate I to perform RNA/DNA extraction, sequencing library construction and Illumina Hiseq sequencer operation in our sequencing team. The successful candidate should have basic knowledge of next generation sequencing using Illumina platform.

    Qualifications
    • M.S. with strong background in molecular biology. Knowledge of cancer biology was preferred.
    • Experience in molecule cloning is a must.
    • Experience in RNA/DNA isolation, preparation for next generation sequencing library was preferred.
    • Demonstrated independence in experimental design, data analysis and interpretation.
    • Strong verbal and written skills.
    • Ability to work in a fast-paced startup environment, meet deadlines, & prioritize work on multiple projects.
    For a prompt consideration, please send your CV to: [email protected]

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...